Biocon’s robust Regulatory team is fully equipped to develop regulatory strategy and manage compliance, risks and dossier submissions across the globe. The team leverages the obtained regulatory approvals to penetrate new markets quickly and cost effectively.
The API team has 50+ APIs, 500+ DMFs or equivalent to their credit, which span the US, EU, Australia, Canada, Japan, China, S. Korea, Brazil, Russia, Mexico, GCC countries, and 300+ domestic and multi-national customers. Our Finished Products team has established a strong footprint in the US and EU having submitted over 10 products to these markets, and a pipeline that stands strong. Our focus now includes China, Brazil, and other global markets.